Clinical trial
Comparison of Topical Antiviral Agents for Labial Cold Sores (Herpes Labialis)
NCT00467662 · Hadassah Medical Organization, Other · Unknown status
Key facts
| NCT number | NCT00467662 |
|---|---|
| Title | Comparison of Topical Antiviral Agents for Labial Cold Sores (Herpes Labialis) |
| Official title | The Safety, Efficacy and Convenience of Use of the Natural Agent "Superlysin Gel" as Treatment for Herpes Labialis in Comparison to Acyclovir 5% and Docozanole 10%. |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Reccurent Herpes Labialis |
| Intervention type | Device, Drug |
| Interventions | Acyclovir 5%, Docosanol 10%, Superlysine gel |
| Enrollment | 75 |
| First posted | May 1, 2007 |
| Last update posted | May 1, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: